GB2311368A - System for detecting malagnancies - Google Patents
System for detecting malagnancies Download PDFInfo
- Publication number
- GB2311368A GB2311368A GB9705942A GB9705942A GB2311368A GB 2311368 A GB2311368 A GB 2311368A GB 9705942 A GB9705942 A GB 9705942A GB 9705942 A GB9705942 A GB 9705942A GB 2311368 A GB2311368 A GB 2311368A
- Authority
- GB
- United Kingdom
- Prior art keywords
- thermogram
- lesion
- produced
- skin
- thermal imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003902 lesion Effects 0.000 claims abstract description 56
- 238000004458 analytical method Methods 0.000 claims abstract description 28
- 230000003211 malignant effect Effects 0.000 claims abstract description 21
- 238000001757 thermogravimetry curve Methods 0.000 claims abstract description 19
- 238000001931 thermography Methods 0.000 claims abstract description 18
- 230000003595 spectral effect Effects 0.000 claims abstract description 13
- 230000037311 normal skin Effects 0.000 claims abstract description 8
- 230000005855 radiation Effects 0.000 claims abstract description 7
- 206010040882 skin lesion Diseases 0.000 claims abstract description 7
- 239000002245 particle Substances 0.000 claims abstract description 4
- 230000000638 stimulation Effects 0.000 claims abstract description 4
- 230000036760 body temperature Effects 0.000 claims abstract description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 15
- 230000036210 malignancy Effects 0.000 claims description 13
- 201000011510 cancer Diseases 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- 238000004422 calculation algorithm Methods 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 238000004141 dimensional analysis Methods 0.000 claims 1
- 238000013528 artificial neural network Methods 0.000 abstract description 7
- 230000004044 response Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 description 12
- 238000005259 measurement Methods 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 9
- 230000009466 transformation Effects 0.000 description 9
- 238000000844 transformation Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 201000001441 melanoma Diseases 0.000 description 6
- 230000000739 chaotic effect Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000010223 real-time analysis Methods 0.000 description 5
- 231100000444 skin lesion Toxicity 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 208000000453 Skin Neoplasms Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- ZXEYZECDXFPJRJ-UHFFFAOYSA-N $l^{3}-silane;platinum Chemical compound [SiH3].[Pt] ZXEYZECDXFPJRJ-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 229910021339 platinum silicide Inorganic materials 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 229910000661 Mercury cadmium telluride Inorganic materials 0.000 description 1
- 208000011586 benign melanocytic skin nevus Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 238000005291 chaos (dynamical) Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
- A61B5/015—By temperature mapping of body part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
A thermal imaging system comprising a thermal imaging device 10 which is able to detect local body temperature at a skin or sub-skin lesion and an adjacent point of normal skin with a resolution not less than 0.1{C. The thermogram produced may be processed by means of software filters in respect of texture, size of particles present, variations in intensity, spectral or spatial distribution, or density or intensity gradients in order to assist in distinguishing between benign and malignant lesions. The thermogram may be analysed with respect to time and a thermogram produced in response to stimulation by infra-red radiation. A neural network may also be used for analysis of the thermogram.
Description
Svstem for Detecting Malignancies
This invention relates to a system for detecting skin and sub-skin malignancies, especially but not exclusively melanoma. Reference to "sub-skin" malignancies means malignancies which lie immediately beneath the skin, such as sub-skin growths of mole-like form. The invention is not intended to include detection of d seated malignancies in respect of which the signal processing techniques heininafter described would in general be inapplicable.
Melanoma is a highly malignant form of skin cancer which manifests itself as a mole-like lesion on the skin. However, at present, a cancerous lesion is not readily distinguishable from a benign mole without clinical examination at a hospital and after histological examination. Somewhat analogously, some forms of sub-skin breast cancer are not readily distinguishable from sub-surface cysts, and require removal and histological examination for proper identification.
Melanoma, particularly, is currently a major concern to the general public and referals of patients to hospitals by doctors in general practice have multiplied in number to such an extent that in many hospitals services are overburdened with clinical examinations for melanoma and analogous cancers to the detriment of other services which have to be carried out by the same personnel.
It would therefore be highly advantageous if a system was available for use by doctors in general practice and capable of reliably testing skin lesions to determine, at least in some cases, whether or not a particular lesion is malignant, thereby reducing the number of hospital referals.
According to the invention, there is provided a thermal imaging system comprising a thermal imaging device capable of detecting the local body temperature at a skin or sub-skin lesion and at an adjacent point of normal skin with a resolution not less than 1/lOth of a degree Centigrade, processing means for processing the output of the thermal imaging device to produce digital signals representative of the detected temperatures, a microprocessor programmed to analyse the temperature representative digital signals and develop video input signals having content indicative of the malignancy and/or non-malignancy of the lesion, and display means for receiving the video input signals and displaying said signals in an interpretable form. The thermal image or thermogram produced will initially be in a raw state. There is provided additional means for the software manipulation of this raw thermogram to produce transformed or processed images.
Thermal imagers (infra-red imagers) have already been used to perform thermography on deep seated malignancies but the end result has always been the obtaining of thermal profiles, that is temperature profiles. This invention allows temperature profiles to be taken in a quantitative and qualitative manner.
Quantitative measures involve the measuring of certain parameters taken from the thermogram (or thermal image). Qualitative measures involve the assessment of the image after the image has been processed in some way, for instance by the use of software filters that transform the image data. Such processing, when suitable filters are used, can make lesions more apparent to the eye, that is qualitatively visible. The transformed images themselves can be assessed in a quantitative manner as well as a qualitative manner, that is the processed or transformed images can be subjected to precise measurement.
Thus, all matter emits infra-red radiation as a function of its absolute temperature, the infra-red energy being produced by molecular activity. As molecules differ so does the infra-red emitted, and in addition the intensity of emissions is dependent upon the number of molecules present. As cells are made up of a variety of different molecules, in varying numbers, a study of the infra-red spectrum, including intensity analysis, arising from a cell and the tissue it forms, enables that cell or tissue to be adequately categorised, as it provides a record of the molecular activity of the cell or tissue. There are several methods of analysis by which a study of infra-red emissions proves fruitful in cancer detection, as follows:1. Total intensity of infra-red emitted, i.e. heat. By measuring the
temperature profile of a lesion and comparing it with the
corresponding profile of the normal surrounds it is sometimes possible
to achieve a discernability that can indicate malignancy.
2. Spatial distribution analysis, referred to herein as texture analysis.
Cancerous molecules may be grouped together intracellularly in a manner
that can be characterised. Moreover cancerous cells may be grouped
together in formations that can be categorised by a textural analysis.
3. Spectral distnbution alaysis. A study of wavelength versus intensity
can be achieved by measuring sub-bands of infra-red as they are emitted.
If in a malignant tissue there are molecules that are actively emitting
infra-red in a particular sub-band and not in another then this technique
will allow them to be categorised.
4. Real time analysis. All tissue is living and therefore subject to
rhythmicity. By analysing the variation of thermographic features with time it is possible to discern certain cancerous lesions from non-cancerous
lesions.
5. Absorption analysis Malignant cells have molecules present that absorb
infra-red in a different manner to molecules present in non-malignant tissue.
This study can be achieved by means of a real time analysis of lesions
after stimulation with an external infra-red source. This technique can
also be performed for differing sub-bands.
Spatial distribution analysis or textural analysis depends upon finding patterns within the raw thermogram, or areas of differing uniformity. To achieve this software filters are used. These are computer programs that process the data held in the raw thermogram via a series of mathematical transformations. Such a process may involve a series of separate transformations in a particular algorithm.
There are several different algorithms which can be used to good effect in transforming the raw thermogram so that the lesion is better seen qualitatively and/or others that produce transformed images that have features that are measurable. Textural analysis is the measurement or assessment of these transformed images.
Thus, in cancerous tissue, malignant cells are grouped together in different ways than are cells in non-malignant tissue. While this grouping may depend upon the results of a variety of factors, such an architecture lends itself to being detected by one or more of the thermographic techniques briefly described above.
A preferred thermal imaging device is a high resolution thermal imaging camera.
One such camera utilises platinum silicide detectors and is thereby capable of detecting infra-red emissions, i.e. infra-red emissions from a suspect lesion and from normal skin. However, the thermal imaging device could alternatively be constituted by a CCD adapted to respond to infra-red wavelengths, or again by a thermal imaging camera utilising HgCdTe sensors.
The device may also include a conventional video camera for viewing a suspect lesion and the adjacent normal skin. The output of the video camera will preferably also be fed to the signal processing means to provide digital signals for input to the microprocessor, which may be programmed to correlate the visual image with the thermal image.
This makes it possible, for example, accurately to determine the size of a lesion and to manipulate the thermal image for ease of interpretation. For example, the thermal image of a suspect lesion may be subtracted from the thermal image of the adjacent normal skin. It is also possible to produce thermal image maps that are representative of intensity levels of infra-red radiation emitted from a lesion both in one and two dimensions.
The thermal image obtained from a lesion can be analysed quantitatively in the following manner. The area of thermal influence of and around a lesion can be plotted in a three dimensional manner, with the area of the lesion being plotted on the x and y coordinates and the temperature at any point on the z coordinate, as shown in Figure 1 of the accompanying drawings. Such a plot enables "temperature volume" measurements to be taken. Temperature volumes are measured in cm x cm x degree Celsuis, and are a measure of the area of thermal influence a lesion has integrated with the temperature of all the points within that area. in the image shown in Figure 1, this temperature volume is the measure of the size of the crater seen (the depth of the crater is a measure of the relative temperature at any one point). The temperature volume can be used as a means of distinguishing the benign or malignant nature of a lesion.
Preferably, the thermal imaging device will be able electrically to pan, scroll and zoom over a suspect lesion, for example to select one or more particular areas of interest, as for cross-point temperature display.
Preferably, it will also be possible to display thermal images in real time, thereby digitally to capture transient thermal events, and also to make real time thermal subtractions enabling temperature comparisons.
The system may also include means for stimulating the suspect lesion to enable the response of the lesion to the stimulator to be measured. The stimulating means may, for example, include means for stimulating the lesion with infra-red radiation, preferably at differing wavelengths, to investigate the response of the lesion to absorption and re-emission of infra-red radiation. The stimulating means may also comprise means for application of a low temperature stimulus, thereby for example to accentuate the temperature difference between the lesion and the adjacent normal skin.
Absolute temperature measurement, although possible, is not a prerequisite for practice of the invention. Most preferably, however, the system will be capable of measuring relative temperatures as between a substantial plurality of points of the surface of the subject at and around the suspect lesion. It will be appreciated that, by virtue of the use of a thermal imaging camera, the points can be as small as individual camera pixels, so that very accurate temperature comparison can be made, preferably at worst of the order of I/lOth of a degree Centigrade.
it will be understood that although the foregoing description refers to lesions as skin lesions which are commonly associated with skin cancer, the system of the invention is also applicable to sub-skin cancers such as breast cancer and malignant lymph node involvement. Spectral distribution analysis enables detailed records to be built up to form a basis for comparisons thereby to enable lesions, whether of malignant or non-malignant nature, to be categorised by their spectral distribution characteristics.
A basic example of a detection system in accordance with the invention is shown in the accompanying drawing, the single figure of which shows the system diagrammatically.
in the drawing, a thermal imaging device 10, for example using platinum silicide detectors, provides an output to an image frame grabber board 12, which also receives image frame signals from a conventional video camera 14. Digital signals output from the grabber board 12 are fed to a microprocessor 16 programmed to produce signals which can be readily interpreted on a monitor screen 18. Optionally, an optical filter 20 can be placed in front of the thermal imager 10 to enable selective detection of certain wavebands.
]n use, the thermal imaging device 10, and likewise the video camera 14, electronically scan a suspect area of a subject, for example a skin lesion, to provide a display which represents, on the basis of differing amounts of infra-red radiation, the temperature differences between the surface of the lesion and the surface of the adjacent normal skin, with a minimum resolution of 1/100th of a degree Centigrade.
Figure 2 of the drawings shows the basic hardware of the detection system.
However, also integral to the system is computer aided analysis software that enables the thermal image to be manipulated in a variety of ways. For instance, this software can enable mapping a two dimensional representation of the suspect lesion with a third dimension representing intensity of the thermal image.
Allowance can be made for plotting additional data relating to spectral distribution onto this map or for enabling spatial distribution of the data, i.e. textural analysis.
Frames grabbed at sequential time periods may be plotted in a manner that allows thermographic data to be plotted against time. Such data may relate to texture, spectral distribution or simple intensity levels, for example. The parameters of thermographic data that are collected by the thermal imager will also be capable of analysis in a variety of ways outlined below.
Textural analysis can be carried out in a variety of ways and relates to a study of the raw thermographic image after it has been processed by a variety of software filters. These show up the texture of the data held within the raw image in ways which produce further images interpretable by simple observational methods or by quantitative analysis. Quantitative analysis may measure the size of particles seen on a transformed image, or can involve the measurement of uniformity. Such patterns or texture produced by variations in intensity, spectral or spatial distribution, density, gradients of intensity can be measured and used as a means of distinguishing benign from malignant lesions.
Spectral analysis can be effected by which means the wavelength of emitted infrared can be plotted against the intensity. This is achieved hy modifying the thermal imager with filters interposed between imager and lesion, so filtering the infra-red energy before it reaches the sensing imager. By using a series of differing filters it will be possible to produce thermal images relating to differing sections of the infra-red spectrum; for instance images corresponding to 10 or 20 nanometre wide wavebands, although any size of waveband is possible.
Real time analysis of the thermal image can also be displayed. Rhythmicity in the infra-red image can be displayed, as can any variation in real time emissions from suspect lesions, and compared to surrounding tissue. A section of skin under study may be selected, either in one dimension or in two, and its behaviour over time recorded, with regard to intensity levels or intensity levels within selected wavebands or with regard to any parameter under study, such as textural analysis.
Real time analysis may take the form of grabbing frames at sequential time periods, say for instance every 10 msec, or up to even 60 seconds.
The real time study of a lesion or a point on the lesion can be recorded as a data plot of activity over time, such activity being intensity of infra red emission or temperature. This "time plot" can be analysed in a variety of ways. Its pattern can be simply analysed quantitatively or it can he subjected to a variety of mathematical transformations. These transformations can be interpreted quantitatively or viewed qualitatively. Such transformations can be used to investigate the periodicity in the time plot, measure its spectral density function or spectral frequency for instance. The transformations can be used as a means of distinguishing benign from malignant lesions. Other techniques used would he to attempt to curve fit the time series or to estimate the randomness of the time series. Measures of the characteristics of such transformations can be used to distinguish benign from malignant lesions.
Real time analysis may occur in other circumstances in order to aid diagnosis of malignancy. With a suspect lesion under study an external infra-red source may be introduced and made to stimulate the suspect lesion for small periods of time.
The response of the lesion during and after stimulation will be noted by the thermal imager. In addition a cold stimulus may be introduced and the response of the lesion noted.
The ability of the thermal imager device to pan, scroll and zoom over a suspect lesion so as to concentrate on particular areas of interest makes it possible for different sections of the image to be analysed, i.e. certain areas of interest highlighted and compared to other areas, be it in one, two or three dimensions, or involving time as a fourth dimension or selected wavebands (sub-infra-red zones) as a fifth dimension.
There are a variety of ways in which textural analysis can be performed in addition to that of the use of software filters for producing transformations of the data.
One such is the technique of looking at boundary sizes and boundray junctions.
Such analysis is effected after boundaries have been made after setting criteria regarding parameters such as intensity levels, spectral distribution, or by correlating images with normal video camera images. Again, by means of techniques used in GIS (geographic imaging by satellite), the computer may be programmed to recognise certain features known to have associations with pathological entities, i.e. the texture of a melanoma is programmed into the computer so that when seen again the computer recognises it as such. Moreover, by means of mathematical modelling, the images analysed may be subjected to pattern recognition for fractal contents and analysis for fractal dimensions.
Boundaries can be produced also on transformed images, such as to delineate the size of a feature seen in a transformed image. These boundaries can contain areas that have certain features deemed of interest, such as an area of conformity with regard to texture, particle size etc. Thus the sizes of any areas of interest can he measured and used as a means of distinguishing benign from malignant.
The digital thermal images can also be analysed by applying chaos theory. A measure of the chaos in the system can be assessed, especially when images are taken in real time. Differences between benign and malignant lesions can he imaged by such analyses. To measure chaos in systems there are a variety of methods that can be employed: amongst these can be the following:
a) measurement of the "correlation dimension" of the system
b) measurement of the "Lyapunov exponent" of the system
c) measurement of "Poincare" cross sectional maps
d) producing phase space diagrams of strange attractors
e) measurement of the fractal dimension
The computerised interpretation of the digital images is undertaken so as to measure these chaotic indicators for different areas of skin and for suspect lesions.
These will then become clinicopathological indices. In addition, the strange attractors present in different clinicopathological states can be compared with the digital data obtained from the imagers, to see if a match can be made. The dimensions of the strange attractors measured can be varied according to the data obtained, but could for instance consist of data relating to real time collection of infra-red intensity levels at any given point or group of points together with spatial distribution data and spectral distribution data as time changes. Additionally there may be recorded rates of change of these parameters which can be utilised to produce chaotic interpretation of the data. Moreover, by measuring changes to the system (skin under study) as it is subjected to external influences such as active infra-red irradiation or cold stimulus it is possible to measure the chaotic parameters and record how they are altered, i.e. the measurements of chaos (correlation dimension and Lyapunov exponents) can be measured not only in the resting state hut also under stressed conditions (after application of external IR or cold stimuli).
From the static images taken pattern analysis can be made, for instance the spatial distribution of IR of a particular intensity can be analysed with regard to the patterns it produces. It is thus possible to model the patterns in a mathematical manner in order to understand the processes that produce them. Of particular interest is the analysis of any fractal qualities in the patterns detected. In this way a clinicopathological label can be given to areas under study, with the aim of enabling benign from disease state to be distinguished.
Of special interest is also the recognition of such measurements of variability as to whether they conform to the patterns associated with chaotic systems, or stable systems, or whether there is any evidence of bifurcations manifesting as hi- or quad-phasic steady state systems. These can then be labelled in a clinicopathological format. Evidence of period doubling behaviour may be evident in different stages of disease and by measuring the behaviour present, whether it be stable, bi-phasic or chaotic, with respect to whichever parameter is elected for measurement, the machine will be capable of establishing clinicopathological entities.
An additional manner in which the realtime data can he analysed is by training a neural network with the data obtained from image recordings and with a knowledge of the pathological outcome after histological analysis. The data fed into the neural network can be of a variety of types, hoth from static images in which textural differences will be foremost or from realtime data where the nonlinear streams of textural data will be witnessed. Textural in this sense can mean any measured infra-red parameter or grouping of parameters analysed for pattern differentiation, and can be analysed from static images or for images that are constantly changing. For instance, the real time data stream may comprise intensity levels of infra-red, spatial distribution data, rate of change in intensity levels and in spatial distribution data, and spectral distribution data, all fed continuously into the neural network over a fixed time period. Without knowing the non-linear relationships that may exist between these and any other types of data inherent within the data stream the neural network will be able to learn how to recognise pathological states, and therefore predict disease states from the data obtained. However, the use of a neural network is not limited by the foregoing,
Such a neural network can be employed in various ways as an interpretive tool.
In any particular system, not all the above-mentioned facilities for analysis may be present. However, it is essential to the invention that the microprocessor is able to output video signals having content which, by means of one or more forms of analysis, can enable malignant and non-malignant lesions, especially melanoma, to be distinguished.
The foregoing description sets out the hasis for a test of malignancy in skin lesions by the following means:1. Analysis of thermal image a) 3D plots temperature v area thermograms measuring "temperature volumes"
b) line profiles over lesions
c) transformations of the raw thermo
grams by the use of software filters
d) qualitative analysis of those lesions
in c)
e) quantitative analysis of those
lesions in c) 2. Analysis of thermal time series a) qualitative assessment
b) tiuantitative assessment
c) transformed time series and
their assessment.
Claims (13)
- ClaimsA A thermal imaging system comnri,ing a thermal imaging device capable of detecting the local body temperature al a skin or sub-skin lesion and at an adjacent point of normal skin with a resolution not less than !/lOth of a degree Centigrade, processing means for processing the output of the thermal imaging device to produce digital signals representative of the detected temperatures, a microprocessor programmed to analyse the temperature representative digital signals and develop video input signals having content indicative of the malignancy andlor non-malignancy of the lesion, and display means for receiving the video input signals and displaying said signals in an interpretable form.
- 2. A system according to claim 1, wherein a temperature profile is produced and displayed and the temperature profile is assessed in a qualitative and/or quantitative manner.
- 3. A system according to claim 2, wherein the temperature profile is a three dimensional thermogram.
- 4. A system according to claim 3, wherein the thermogram is analysed in repect of ite x. y and z coordirates.
- 5. A system according to claim 4, wherein temperature volumes are derived from the three dimensional analysis to assist in distinguishing between benign and malignant lesions.
- 6. A system according to any of claims 1 to 4, wherein a raw thermogram is produced and transformed by algorithms to produce a qualitatively or quantitatively assessible refined thermogram.
- ?. A system according to any of claims 1 to 6, wherein a raw thermogram is produced and processed hy means of software filters in respect of texture andlor size of particles present and!or variations in respect of intensity, spectral or spatial distribution, density and/or intensity gradients to assist in distinguishing between benign and malignant lesions.
- 8. A system according to any of claims 1 to 7, wherein a thermogram is produced and analysed with respect to time.
- 9. A system according to any of claims 1 to 8, wherein a thermogram is produced responsively to stimulation of the lesion by infra-red radiation.
- 10. A system according to any of claims 1 to 9, including a video camera for viewing the lesion and supplying output signals to the processing means.
- 11. A syslem according to any of claims 1 to 10, wherein the thermal imaging device is adapted to pan, scroll and zoom over a lesion under test.
- 12. A system according to any of claims 1 to Ii, wherein a thellnoElam is produced and displayed in real time.
- 13. A system substanliallx as hereinbefore desciil)ed with iefeieice to the accompanying drawings.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9606124.7A GB9606124D0 (en) | 1996-03-22 | 1996-03-22 | System for detecting cancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB9705942D0 GB9705942D0 (en) | 1997-05-07 |
| GB2311368A true GB2311368A (en) | 1997-09-24 |
| GB2311368B GB2311368B (en) | 1999-09-22 |
Family
ID=10790891
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9606124.7A Pending GB9606124D0 (en) | 1996-03-22 | 1996-03-22 | System for detecting cancers |
| GB9705942A Expired - Fee Related GB2311368B (en) | 1996-03-22 | 1997-03-21 | System for detecting malignancies |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9606124.7A Pending GB9606124D0 (en) | 1996-03-22 | 1996-03-22 | System for detecting cancers |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB9606124D0 (en) |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2319336A (en) * | 1996-11-08 | 1998-05-20 | Gary Rogers | Skin malignancy detecting system |
| EP0885587A1 (en) * | 1997-06-17 | 1998-12-23 | David Keith Harrison | Thermal imaging method and apparatus |
| WO2001035819A1 (en) * | 1999-11-17 | 2001-05-25 | Glaxo Group Limited | Infrared thermography |
| DE19956346A1 (en) * | 1999-11-24 | 2001-05-31 | Reinhold Berz | Comparative thermal imaging technique of the human body, useful for medical diagnosis |
| WO2001001854A3 (en) * | 1999-07-02 | 2001-09-13 | Hypermed Imaging Inc | Integrated imaging apparatus |
| WO2002082029A1 (en) * | 2001-04-03 | 2002-10-17 | Welch Allyn, Inc. | Infrared thermometer |
| WO2002094097A1 (en) * | 2001-05-18 | 2002-11-28 | Polartechnics Limited | Boundary finding in dermatological examination |
| US6881584B1 (en) | 1998-05-15 | 2005-04-19 | Smithkline Beecham Corporation | Infrared thermography |
| EP1105042A4 (en) * | 1998-05-27 | 2005-07-20 | Omnicorder Technologies Inc | METHOD FOR DETECTING CARCINOGENIC LESIONS |
| US6983753B1 (en) | 1999-11-17 | 2006-01-10 | Smithkline Beecham Corporation | Infrared thermography |
| AU2002308394B2 (en) * | 2001-05-18 | 2006-11-23 | Polartechnics Limited | Boundary finding in dermatological examination |
| DE102006024501A1 (en) * | 2006-05-26 | 2007-11-29 | Rafail Rabkin | Human organ temperature measurement method for e.g. mercury thermometer, involves evaluating measuring values for temperature of skin of human by statistical method and neural network for temperature, and displaying organ temperature |
| WO2008030427A3 (en) * | 2006-09-06 | 2008-07-03 | Intellectual Ventures Holding | Passive in vivo substance spectroscopy |
| US7750299B2 (en) | 2006-09-06 | 2010-07-06 | Donald Martin Monro | Active biometric spectroscopy |
| US7786907B2 (en) | 2008-10-06 | 2010-08-31 | Donald Martin Monro | Combinatorial coding/decoding with specified occurrences for electrical computers and digital data processing systems |
| US7786903B2 (en) | 2008-10-06 | 2010-08-31 | Donald Martin Monro | Combinatorial coding/decoding with specified occurrences for electrical computers and digital data processing systems |
| US7791513B2 (en) | 2008-10-06 | 2010-09-07 | Donald Martin Monro | Adaptive combinatorial coding/decoding with specified occurrences for electrical computers and digital data processing systems |
| DE102009018633A1 (en) | 2009-04-17 | 2010-10-21 | Technische Universität Dresden | Method and device for intraoperative imaging of brain areas |
| US7864086B2 (en) | 2008-10-06 | 2011-01-04 | Donald Martin Monro | Mode switched adaptive combinatorial coding/decoding for electrical computers and digital data processing systems |
| WO2012050495A1 (en) * | 2010-10-14 | 2012-04-19 | Performance In Cold Ab | Method and device for examining the surface temperature of a body part |
| US9307912B2 (en) | 2012-08-08 | 2016-04-12 | Welch Allyn, Inc. | Temperature measurement system |
| CN112117001A (en) * | 2020-09-08 | 2020-12-22 | 深圳市智慧健康产业发展有限公司 | General practitioner intelligence image auxiliary diagnosis system |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310003A (en) * | 1978-02-06 | 1982-01-12 | Schlager Kenneth J | Thermographic method of physical examination of patients |
| US4428382A (en) * | 1980-09-03 | 1984-01-31 | Gst Laboratories, Inc. | Method for identifying the presence of abnormal tissue |
| US4445516A (en) * | 1980-05-29 | 1984-05-01 | Carl Zeiss-Stiftung | Process for the digitization and display of thermographic records |
-
1996
- 1996-03-22 GB GBGB9606124.7A patent/GB9606124D0/en active Pending
-
1997
- 1997-03-21 GB GB9705942A patent/GB2311368B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310003A (en) * | 1978-02-06 | 1982-01-12 | Schlager Kenneth J | Thermographic method of physical examination of patients |
| US4445516A (en) * | 1980-05-29 | 1984-05-01 | Carl Zeiss-Stiftung | Process for the digitization and display of thermographic records |
| US4428382A (en) * | 1980-09-03 | 1984-01-31 | Gst Laboratories, Inc. | Method for identifying the presence of abnormal tissue |
Cited By (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2319336A (en) * | 1996-11-08 | 1998-05-20 | Gary Rogers | Skin malignancy detecting system |
| GB2319336B (en) * | 1996-11-08 | 2001-05-23 | Gary Rogers | System for detecting malignancies |
| EP0885587A1 (en) * | 1997-06-17 | 1998-12-23 | David Keith Harrison | Thermal imaging method and apparatus |
| US6881584B1 (en) | 1998-05-15 | 2005-04-19 | Smithkline Beecham Corporation | Infrared thermography |
| EP1105042A4 (en) * | 1998-05-27 | 2005-07-20 | Omnicorder Technologies Inc | METHOD FOR DETECTING CARCINOGENIC LESIONS |
| WO2001001854A3 (en) * | 1999-07-02 | 2001-09-13 | Hypermed Imaging Inc | Integrated imaging apparatus |
| US6640130B1 (en) | 1999-07-02 | 2003-10-28 | Hypermed, Inc. | Integrated imaging apparatus |
| WO2001035819A1 (en) * | 1999-11-17 | 2001-05-25 | Glaxo Group Limited | Infrared thermography |
| US6983753B1 (en) | 1999-11-17 | 2006-01-10 | Smithkline Beecham Corporation | Infrared thermography |
| DE19956346B4 (en) * | 1999-11-24 | 2004-03-18 | Berz, Reinhold, Dr. | Device for determining the temperature distribution on the body surface of a person |
| DE19956346A1 (en) * | 1999-11-24 | 2001-05-31 | Reinhold Berz | Comparative thermal imaging technique of the human body, useful for medical diagnosis |
| US6631287B2 (en) | 2001-04-03 | 2003-10-07 | Welch Allyn, Inc. | Infrared thermometer |
| WO2002082029A1 (en) * | 2001-04-03 | 2002-10-17 | Welch Allyn, Inc. | Infrared thermometer |
| AU2002308394B2 (en) * | 2001-05-18 | 2006-11-23 | Polartechnics Limited | Boundary finding in dermatological examination |
| WO2002094097A1 (en) * | 2001-05-18 | 2002-11-28 | Polartechnics Limited | Boundary finding in dermatological examination |
| DE102006024501A1 (en) * | 2006-05-26 | 2007-11-29 | Rafail Rabkin | Human organ temperature measurement method for e.g. mercury thermometer, involves evaluating measuring values for temperature of skin of human by statistical method and neural network for temperature, and displaying organ temperature |
| WO2008030427A3 (en) * | 2006-09-06 | 2008-07-03 | Intellectual Ventures Holding | Passive in vivo substance spectroscopy |
| US7750299B2 (en) | 2006-09-06 | 2010-07-06 | Donald Martin Monro | Active biometric spectroscopy |
| US7864086B2 (en) | 2008-10-06 | 2011-01-04 | Donald Martin Monro | Mode switched adaptive combinatorial coding/decoding for electrical computers and digital data processing systems |
| US7786903B2 (en) | 2008-10-06 | 2010-08-31 | Donald Martin Monro | Combinatorial coding/decoding with specified occurrences for electrical computers and digital data processing systems |
| US7791513B2 (en) | 2008-10-06 | 2010-09-07 | Donald Martin Monro | Adaptive combinatorial coding/decoding with specified occurrences for electrical computers and digital data processing systems |
| US7786907B2 (en) | 2008-10-06 | 2010-08-31 | Donald Martin Monro | Combinatorial coding/decoding with specified occurrences for electrical computers and digital data processing systems |
| DE102009018633A1 (en) | 2009-04-17 | 2010-10-21 | Technische Universität Dresden | Method and device for intraoperative imaging of brain areas |
| WO2012050495A1 (en) * | 2010-10-14 | 2012-04-19 | Performance In Cold Ab | Method and device for examining the surface temperature of a body part |
| CN103338694A (en) * | 2010-10-14 | 2013-10-02 | 冷性能公司 | Method and device for examining the surface temperature of a body part |
| CN103338694B (en) * | 2010-10-14 | 2016-02-10 | 冷性能公司 | For the method and apparatus of the surface temperature of part of having a physical examination |
| US9918644B2 (en) | 2010-10-14 | 2018-03-20 | Performance In Cold Ab | Method for examining the surface temperature of a body part |
| US9307912B2 (en) | 2012-08-08 | 2016-04-12 | Welch Allyn, Inc. | Temperature measurement system |
| US9474450B2 (en) | 2012-08-08 | 2016-10-25 | Welch Allyn, Inc. | Temperature measurement system |
| US9901258B2 (en) | 2012-08-08 | 2018-02-27 | Welch Allyn, Inc. | Temperature measurement system |
| CN112117001A (en) * | 2020-09-08 | 2020-12-22 | 深圳市智慧健康产业发展有限公司 | General practitioner intelligence image auxiliary diagnosis system |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2311368B (en) | 1999-09-22 |
| GB9606124D0 (en) | 1996-05-22 |
| GB9705942D0 (en) | 1997-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2311368A (en) | System for detecting malagnancies | |
| US7519210B2 (en) | Method of assessing localized shape and temperature of the human body | |
| Çetingül et al. | Quantification of the thermal signature of a melanoma lesion | |
| Tidhar et al. | Modeling human search and target acquisition performance: IV. Detection probability in the cluttered environment | |
| EP1620003B1 (en) | System and method for identifying and classifying dynamic thermodynamic processes in mammals and discriminating between and among such processes | |
| US20040076316A1 (en) | Method and apparatus for measuring physiology by means of infrared detector | |
| US9691147B2 (en) | Method and system for feature extraction and decision making from series of images | |
| US20060116555A1 (en) | Controlled environment thermal image detection system and methods regarding same | |
| Fabelo et al. | A novel use of hyperspectral images for human brain cancer detection using in-vivo samples | |
| CA2258124A1 (en) | Dermal diagnostic analysis system and method | |
| US20070161910A1 (en) | Method and Apparatus for Detecting the Presence of Dermal Melanin in Epithelial Tissue | |
| Bardhan et al. | A review on inflammatory pain detection in human body through infrared image analysis | |
| Voigt et al. | Topodermatographic image analysis for melanoma screening and the quantitative assessment of tumor dimension parameters of the skin | |
| CN106725358A (en) | A kind of ward measurement of bldy temperature data collecting system | |
| US8233968B1 (en) | Method and apparatus for high resolution dynamic digital infrared imaging | |
| CN113164068A (en) | Method and system for processing thermometric video images | |
| RU2189732C2 (en) | Method for early forest pathology diagnosis | |
| US20130023773A1 (en) | Apparatus and techniques of non-invasive analysis | |
| US7408156B2 (en) | System and method for identifying and classifying dynamic thermodynamic processes in mammals and discriminating between and among such processes | |
| Kapoor et al. | Real time intelligent thermal analysis approach for early diagnosis of breast cancer | |
| Pirtini C¸ etingu¨ l et al. | Quantitative evaluation of skin lesions using transient thermal imaging | |
| GB2319336A (en) | Skin malignancy detecting system | |
| CN114027803A (en) | Internal balance detection device based on temperature field distribution | |
| Qianruixue et al. | Evaluation of ocular surface temperature of contact lens wearer using thermograms | |
| Liao et al. | An experimental study on object recognition and enhancement in MWIR thermography |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20010321 |